Table 1.
Reference | McQualter et al.; Stem Cells 2008 |
Teisanu et al.; Stem Cells 2008 |
Kim et al.; Cell2005 |
Summer et al.; AJRCMB 2007 |
---|---|---|---|---|
Isolation Optimized For: |
-- | Bronchiolar Cells | Alveolar Cells | Epithelial Cell Exclusion |
Digestive Enzyme(s) / Enrichment Strategies |
Collagenase Density gradient centrifugation |
PBS/EGTA Elastase DNase |
Dispase Collagenase Agarose DNase |
Collagenase Dispase |
Stem / Progenitor Phenotype |
CD45- CD31- Sca-1+ CD34+(a) Thy-1(b) |
CD45- CD31- Sca-1low CD34-A plow/hi (d) |
CD45- CD31- Sca-1+ CD34+ |
SP CD45- CD31- Sca-l+(e) (others)(e) |
Stem / Progenitor Cell Type |
Mesenchymal | Epithelial (Bronchiolar) |
Epithelial | Mesenchymal |
Primary Culture Media / Conditions |
Low Oxygen; 20% serum OR defined serum-free media |
ND | 10% serum | 20% serum (SP); 10% serum (non- SP) |
Primary Culture Substrate |
Laminin-coated plates |
ND | On MEFs | Plastic |
In vitro Differentiation Capacity |
Cartilage, Bone(c); Fat (bFGF supplement); Fat/ Fibroblastic Cells (ALI culture) |
ND | Alveolar and Bronchiolar Lineages (on Matrigel) |
Smooth Muscle, Cartilage, Bone, Fat (published differentiation protocols) |
In vitro Self-renewal Potential |
Yes (clonogenic assays, LD) |
ND | Yes (serial passaging, clonogenic assays, LD) |
Yes (serial passaging) |
Sca-1 In situ Expression |
Endothelium, Distal parenchyma |
Endothelium, Proximal airway epithelium |
Endothelium, Ciliated Cells, BASCs |
Endothelium (Summer et al., 2003) |
analysis only; not used to sort populations for in vitro assays
heterogeneous expression; Thy-1hi and Thy-1low fractions show distinct potential in culture assays
data not published
AF = autofluorescence in the AlexaFluor 647 and PE channels; low = stem cells, high = facultative transit-amplifying cells
expression determined after long-term culturing
Abbreviations: ALI = air-liquid interface; LD = limiting dilution; ND = not determined; MEFs = mouse embryonic fibroblasts